Harbor Capital Advisors, Inc. Catalent, Inc. Transaction History

Harbor Capital Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$42.56 - $59.82 $148,279 - $208,412	3,484 Added 32.08%	14,344 $810,000
Q4 2023 Jan 08, 2024	BUY	$32.18 - $46.57 $28,125 - $40,702	874 Added 8.75%	10,860 $487,000
Q3 2023 Oct 20, 2023	BUY	$44.2 - $50.2 $62,631 - $71,133	1,417 Added 16.54%	9,986 $454,000
Q2 2023 Jul 11, 2023	BUY	$31.86 - $67.26 $24,054 - $50,781	755 Added 9.66%	8,569 $371,000
Q1 2023 Apr 26, 2023	BUY	$45.44 - $74.26 $102,512 - $167,530	2,256 Added 40.59%	7,814 $513,000
Q4 2022 Jan 20, 2023	SELL	$41.39 - $81.0 $4,966 - $9,720	-120 Reduced 2.11%	5,558 $0
Q3 2022 Oct 28, 2022	SELL	$72.36 - $113.1 $373,667 - $584,048	-5,164 Reduced 47.63%	5,678 $411,000
Q2 2022 Jul 26, 2022	BUY	$87.2 - $114.05 $15,172 - $19,844	174 Added 1.63%	10,842 $1.16 Million
Q1 2022 Apr 28, 2022	SELL	$94.19 - $124.49 $174,628 - $230,804	-1,854 Reduced 14.81%	10,668 $1.18 Million
Q4 2021 Feb 04, 2022	BUY	$119.57 - $139.07 $1.5 Million - $1.74 Million	12,522 New	12,522 $1.6 Million

489

165M

364K

837K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.